This review systematically evaluates recent advances in lipid-based, polymeric, peptide, and exosome-derived nanocarriers, focusing on their design principles, mechanisms of uptake, and endosomal escape strategies, and highlights both the promise and the limitations of nanoparticle-mediated CRISPR/Cas9 RNP delivery.
V. Rajeshwar, Konda Ravi Kumar, Gollapalli Rajeev Kumar et al.· Current Gene Therapy· 0 citations
Comparative studies show that interventions based on nanocarrier-based therapies enhance therapeutic efficacy and safety profiles in preclinical AD models, and future directions include integrating AI-driven nano-design, gene and siRNA delivery, and precision neuropharmacology to enable personalized anti-inflammatory t...
Sumit Kaushik, Jamal E. Fatima, Amatul Raheem et al.· InflammoPharmacology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.